85
Participants
Start Date
March 31, 2001
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Rituximab
375 mg/m\^2 by vein over 3 to 8 hours weekly for 6 weeks in a row.
Adriamycin
25 mg/m\^2 injected by vein over 3 hours every other week for a total of 12 treatments.
Bleomycin
10 U/m\^2 injected by vein over 3 hours every other week for a total of 12 treatments.
Vinblastine
6 mg/m\^2 injected by vein over 3 hours every other week for a total of 12 treatments.
Dacarbazine (DTIC)
375 mg/m\^2 injected by vein over 3 hours every other week for a total of 12 treatments.
UT MD . Anderson Cancer Center, Houston
Collaborators (1)
Genentech, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER